Current Issue

Biopharma Asia

March/April 2018 | Volume 7 Issue 2


Advances and Challenges in Vaccine Development and Manufacture

Tony D’Amore, Vice-President, Global Product Research & Development Sanofi Pasteur


A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Director Development Analytics Roche Diagnostics GmbH, Germany


Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...

Bonnie K. Shum, Engineer II (Global Biologics MSAT) Genentech Inc., A member of the Roche...


Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Associate Principal Scientist Ian Ashworth, Associate Principal Scientist A...


Development and Implementation of Process Analytical Technology (PAT) Systems in the Bioph...

Sameer Talwar1, Benoit Igne2, Juan Aon3, Dave Stevenson3, Janice Fernandez3, Diana Ritz3, ...


Is automation the disruption pharma R&D needs?

Barbara Paldus, PhD, Vice President and General Manager, Finesse, a part of Thermo Fisher ...